Lapelga vs Gastrofil

PHASE3Not yet recruitingINTERVENTIONAL
Enrollment

74

Participants

Timeline

Start Date

November 1, 2023

Primary Completion Date

November 1, 2024

Study Completion Date

November 1, 2025

Conditions
Multiple MyelomaLymphomaEngagement, PatientFebrile Neutropenia
Interventions
DRUG

Grastofil®

On day 5 after the hemopoietic stem cell transplant, one subcutaneous injection for 5 days

DRUG

Lapelga

On day 5 after the hemopoietic stem cell transplant, one subcutaneous injection

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Apobiologix.

UNKNOWN

lead

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

OTHER

NCT06116734 - Lapelga vs Gastrofil | Biotech Hunter | Biotech Hunter